Increase Childhood Immunizations
MaineHealth continues to collaborate with organizations to implement clinical, community, and policy strategies to increase on-time childhood immunization rates in Maine.
Maine's 2015 estimated up-to-date rate among all 19-35 month olds is 72%
Up-to-Date on 7 Immunizations
Results of the 2015 National Immunization Survey (NIS) released by the U.S. Centers for Disease Control and Prevention indicate that an estimated 71.8% (95% CI ±5.0) of Maine’s children aged 19-35 months were up-to-date on a combined series of seven vaccines* compared to the national average of 72.2%. The 2015 rate represents a significant decrease from the 2014 estimated rate of 85%, however the 2015 rate is not statistically different from the majority of states. Only 1 State (Texas) had a statistically significant increase in their Up-to-Date rate of 7 vaccines from 2014 to 2015.
Both the Maine and U.S. estimates were below the HealthyPeople 2020 target of 80% and the MaineHealth goal rate of 85%.
DTap - (Diphtheria, tetanus, acellular pertussis) The estimated rate for DTap coverage of 92% is the highest in the U.S. and above the HealthyPeople 2020 goal of 90% and statistically above that of 5 other states.
Polio - The estimated Polio vaccine rate in Maine is 95%, slightly above the U.S. estimate as well as the Healthy People 2020 target of 90%. There is much consistency in the Polio vaccine rate across the United States with only 2 states statistically above the U.S. estimate and none below.
MMR - (Measles, Mumps and Rubella) vaccine rates are also very consistent across the U.S. with only 2 states statistically above the U.S. average and only 1 below. The Maine estimate of 96% and U.S. estimate of 92% are both above the Healthy People 2020 goal of 90%.
HepB - (Hepatitis B) The Maine vaccine rate estimate for HepB ≥3 doses was 89%, only slightly below the HP2020 target of 90%. The majority of U.S. states have an estimated immunization rate for HepB that is above the target.
Varicella - The estimated immunization rate of 93.8% is very similar to the 2014 estimate of 94.5%. The varicella estimate is above the Healthy People target of 90% in Maine and in the U.S. overall. Only 1 state has an estimate statistically below and 3 above the U.S. estimate.
PCV - (Pneumococcal conjugate vaccine) - The estimate of PCV vaccine coverage in Maine is 85%, slightly above the overall U.S. estimate of 84%. Both the US and Maine rate estimates are below the Healthy People 202 target of 90%.
Teen Human Papiloma Virus (HPV) immunization rates for females receiving ≥doses in Maine remained virtually unchanged from 2014 to 2015 (44%) however the rate for males ≥3 doses HPV rose from 28% to 47%, a statistically significant increase. This increase of almost 20 points was the second largest of all U.S. states.
*series of 7 vaccines include ≥4 DTaP, ≥3 IPV, ≥1 MMR, full HIB series, ≥ 3 HepB, ≥ 1 VAR, ≥ 4 PCV
- Provide training, assessments, feedback and incentives for providers.
- Expand use of provider reminders and standing orders.
- Expand access to vaccination services, data and combination vaccines.
- Provide vaccine education during prenatal visits.
- Expand use of 2-way communication between Electronic Health Records (EHRs) and ImmPact.
- Expand the ease and use of ImmPact across all sites.
- Maintain provider reimbursement.
- Implement patient reminder and recall systems and system-based enhancements.
- Engage and educate vaccine-hesitant families.
- Implement evidence-based interventions that focus on:
- Increasing community demand for vaccines.
- Enhancing access to vaccination services.
- Improve community engagement in interventions.
- Advocate for and implement policies that expand access, improve monitoring, enhance requirements and increase vaccination rates.
- Improve regional surveillance efforts.